Edition:
United Kingdom

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

26.92CAD
19 Jan 2018
Change (% chg)

$-0.50 (-1.82%)
Prev Close
$27.42
Open
$27.38
Day's High
$27.38
Day's Low
$26.24
Volume
1,826,599
Avg. Vol
1,989,321
52-wk High
$30.56
52-wk Low
$11.20

Latest Key Developments (Source: Significant Developments)

Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Valeant Pharmaceuticals International Inc ::ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-121 ACNE TREATMENT IN LOTION FORM.ORTHO DERMATOLOGICS - PDUFA ACTION DATE IS AUG. 27, 2018.  Full Article

Valeant Pays Down $300 Million Of Senior Secured Term Loans
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Valeant Pharmaceuticals International Inc ::VALEANT PAYS DOWN $300 MILLION OF SENIOR SECURED TERM LOANS.VALEANT - AS OF DEC. 31, 2017, COMPANY'S TOTAL DEBT IS APPROXIMATELY $25.7 BILLION.VALEANT - IN AGGREGATE, VALEANT HAS NOW REDUCED ITS DEBT BY MORE THAN $6.5 BILLION SINCE END OF Q1 OF 2016.  Full Article

Bausch + Lomb Receives FDA Approval Of Lumify
Friday, 22 Dec 2017 

Dec 22 (Reuters) - Valeant Pharmaceuticals International Inc ::BAUSCH + LOMB RECEIVES FDA APPROVAL OF LUMIFY™ - THE ONLY OVER-THE-COUNTER EYE DROP WITH LOW-DOSE BRIMONIDINE FOR THE TREATMENT OF EYE REDNESS.VALEANT - EXPECT LUMIFY WILL BE AVAILABLE FOR PURCHASE IN MAJOR RETAILERS IN Q2 OF 2018.  Full Article

Valeant Completes Sale Of Sprout Pharmaceuticals Subsidiary To Former Shareholders Of Sprout
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Valeant Pharmaceuticals International Inc ::VALEANT COMPLETES SALE OF SPROUT PHARMACEUTICALS SUBSIDIARY TO FORMER SHAREHOLDERS OF SPROUT PHARMACEUTICALS.VALEANT - BEEN RELEASED FROM ONGOING OBLIGATIONS OF ORIGINAL DEAL TO SPLIT FUTURE PROFITS RELATED TO SALE OF ADDYI WITH FORMER SHAREHOLDERS OF SPROUT.VALEANT - PARTIES TO LITIGATION AGAINST CO BROUGHT BY FORMER SHAREHOLDERS OF SPROUT FILED JOINT STIPULATION WITH COURT THAT SUCH CLAIMS BE DISMISSED.  Full Article

Amphastar Announces Approval For Sodium Nitroprusside Injection, USP
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Amphastar Pharmaceuticals Inc ::AMPHASTAR ANNOUNCES APPROVAL FOR SODIUM NITROPRUSSIDE INJECTION, USP.AMPHASTAR PHARM - ANTICIPATES LAUNCHING SODIUM NITROPRUSSIDE INJECTION, USP IN Q1 OF 2018.AMPHASTAR PHARMACEUTICALS - FDA GRANTED APPROVAL OF ABBREVIATED NEW DRUG APPLICATION FOR SODIUM NITROPRUSSIDE INJECTION 25MG/ML, 2ML SINGLE DOSE VIAL.  Full Article

Valeant - ‍Bausch + Lomb Announced That It Has Begun Distributing Vyzulta 0.024% To U.S. Wholesale Pharmaceutical Distributors​
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Valeant Pharmaceuticals International Inc ::VALEANT - ‍BAUSCH + LOMB ANNOUNCED THAT IT HAS BEGUN DISTRIBUTING VYZULTA 0.024% TO U.S. WHOLESALE PHARMACEUTICAL DISTRIBUTORS​.  Full Article

Valeant Announces Pricing Of Private Offering Of Senior Notes
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Valeant Pharmaceuticals International Inc ::VALEANT ANNOUNCES PRICING OF PRIVATE OFFERING OF SENIOR NOTES.VALEANT - HAS PRICED ITS PREVIOUSLY ANNOUNCED OFFERING OF 9.000% SENIOR NOTES DUE 2025.VALEANT - OFFERING PRICE FOR NOTES WAS 98.611%.VALEANT - NOTE OFFERING IS EXPECTED TO CLOSE ON OR ABOUT DECEMBER 18, 2017.  Full Article

Valeant, Unit Announce Upsize of Cash Tender Offers
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Valeant Pharmaceuticals International Inc ::VALEANT AND ONE OF ITS SUBSIDIARIES ANNOUNCE UPSIZE OF CASH TENDER OFFERS TO $1,500,000,000 OUTSTANDING PRINCIPAL AMOUNT.VALEANT - TENDER OffERS WILL EXPIRE ON JANUARY 2, 2018.VALEANT - CO, VPI ANNOUNCED THAT THEY HAVE INCREASED MAXIMUM AMOUNT OF NOTES THAT MAY BE PURCHASED PURSUANT TO TENDER OFFERS FROM $1 BILLION TO $1.5 BILLION.VALEANT - NO MORE THAN $200 MILLION OF 5.375% SENIOR NOTES DUE 2020 WILL BE PURCHASED IN TENDER OFFERS.  Full Article

Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1 bln Outstanding Principal Amount
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Valeant Pharmaceuticals International Inc ::VALEANT AND ONE OF ITS SUBSIDIARIES COMMENCE CASH TENDER OFFERS FOR UP TO $1,000,000,000 OUTSTANDING PRINCIPAL AMOUNT.VALEANT - ‍TENDER OFFERS WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON JANUARY 2, 2018​.  Full Article

Valeant Announces Launch Of Private Offering Of Senior Notes
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Valeant Pharmaceuticals International Inc ::VALEANT ANNOUNCES LAUNCH OF PRIVATE OFFERING OF SENIOR NOTES.VALEANT - LAUNCHED OFFERING OF $1 BILLION AGGREGATE PRINCIPAL AMOUNT OF UNSECURED SENIOR NOTES DUE 2025.VALEANT - INTENDS TO USE OFFERING'S NET PROCEEDS TO REPURCHASE $1 BILLION AGGREGATE PRINCIPAL AMOUNT OF ITS OUTSTANDING 5.375% SENIOR NOTES DUE 2020.VALEANT - ‍ TO USE PROCEEDS ALONG WITH CASH TO ALSO REPURCHASE UNIT'S OUTSTANDING 7.000% SENIOR NOTES DUE 2020 AND 6.375% SENIOR NOTES DUE 2020​.VALEANT - ‍ PROVIDED NOTICE TO LENDERS OF INTENT TO REPAY $175 MILLION OF AMOUNTS OUTSTANDING UNDER REVOLVING CREDIT FACILITY THIS WEEK, USING CASH ON HAND​.  Full Article